Komu pomagamyNasza naukaProduktyWyniki
Zaloguj sięZapytajZamówod 449 $
Cecha
Undescended testes
Nazwa kliniczna: Cryptorchidism
Testis in inguinal canal. That is, absence of one or both testes from the scrotum owing to failure of the testis or testes to descend through the inguinal canal to the scrotum.
Podsumowanie
- Znana także jako
- Undescended testis, Cryptorchism
- Układ organizmu
- Abnormality of the genitourinary system
Undescended testesHP:0000028
Komu pomagamyNasza naukaProduktyWyniki
Zaloguj sięZapytajZamówod 449 $
Read the genes linked to Undescended testes, and the rest of your genome, with one test.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni
Zamawiam Genome Test791 genów powiązanych z Undescended testes
Zmiany w tych genach powodują rzadkie choroby, w których występuje Undescended testes. Większość osób z tą cechą nie ma żadnej z tych chorób, a gen z tej listy nic nie mówi o czyimkolwiek własnym genomie.
| Gen | Jak często występuje | Choroby |
|---|---|---|
| ABCB7ATP binding cassette subfamily B member 7 | Zawsze | W 2 chorobach |
| AFF4ALF transcription elongation factor 4 | Zawsze | W 1 chorobie |
| ALG12ALG12 alpha-1,6-mannosyltransferase | Zawsze | W 2 chorobach |
| ANKLE2ankyrin repeat and LEM domain containing 2 | Zawsze | W 1 chorobie |
| ARandrogen receptor | Zawsze | W 2 chorobach |
| ARID1AAT-rich interaction domain 1A | Zawsze | W 2 chorobach |
| ARNT2aryl hydrocarbon receptor nuclear translocator 2 | Zawsze | W 2 chorobach |
| ASH1LASH1 like histone lysine methyltransferase | Zawsze | W 1 chorobie |
| ATP6V1E1ATPase H+ transporting V1 subunit E1 | Zawsze | W 1 chorobie |
| BBS4Bardet-Biedl syndrome 4 | Zawsze | W 2 chorobach |
| CACHD1cache domain containing 1 | Zawsze | W 1 chorobie |
| CCDC32coiled-coil domain containing 32 | Zawsze | W 1 chorobie |
| CDC6cell division cycle 6 | Zawsze | W 2 chorobach |
| CHASERRCHD2 adjacent suppressive regulatory RNA | Zawsze | W 1 chorobie |
| CHRNGcholinergic receptor nicotinic gamma subunit | Zawsze | W 2 chorobach |
| COL3A1collagen type III alpha 1 chain | Zawsze | W 1 chorobie |
| DEPDC5DEP domain containing 5, GATOR1 subcomplex subunit | Zawsze | W 1 chorobie |
| DHDDSdehydrodolichyl diphosphate synthase subunit | Zawsze | W 2 chorobach |
| DLX4distal-less homeobox 4 | Zawsze | W 1 chorobie |
| DONSONDNA replication fork stabilization factor DONSON | Zawsze | W 1 chorobie |
| DVL3dishevelled segment polarity protein 3 | Zawsze | W 2 chorobach |
| EEDembryonic ectoderm development | Zawsze | W 1 chorobie |
| ERCC6ERCC excision repair 6, chromatin remodeling factor | Zawsze | W 4 chorobach |
| ERCC8ERCC excision repair 8, CSA ubiquitin ligase complex subunit | Zawsze | W 3 chorobach |
| ESAMendothelial cell adhesion molecule | Zawsze | W 1 chorobie |
| EXT2exostosin glycosyltransferase 2 | Zawsze | W 2 chorobach |
| FAAP100FA core complex associated protein 100 | Zawsze | W 2 chorobach |
| FAT4FAT atypical cadherin 4 | Zawsze | W 1 chorobie |
| FEZF1FEZ family zinc finger 1 | Zawsze | W 3 chorobach |
| FKRPfukutin related protein | Zawsze | W 3 chorobach |
| FKTNfukutin | Zawsze | W 2 chorobach |
| FLVCR1FLVCR choline and heme transporter 1 | Zawsze | W 1 chorobie |
| FRYLFRY like transcription coactivator | Zawsze | W 1 chorobie |
| GATA4GATA binding protein 4 | Zawsze | W 4 chorobach |
| GINS3GINS complex subunit 3 | Zawsze | W 1 chorobie |
| GSCgoosecoid homeobox | Zawsze | W 1 chorobie |
| H4C9H4 clustered histone 9 | Zawsze | W 1 chorobie |
| HNRNPKheterogeneous nuclear ribonucleoprotein K | Zawsze | W 3 chorobach |
| HYAL2hyaluronidase 2 | Zawsze | W 1 chorobie |
| IRX5iroquois homeobox 5 | Zawsze | W 1 chorobie |
Pokaż jeszcze 751 genów
| Gen | Jak często występuje | Choroby |
|---|---|---|
| ITPR1inositol 1,4,5-trisphosphate receptor type 1 | Zawsze | W 1 chorobie |
| JKAMPJNK1/MAPK8 associated membrane protein | Zawsze | W 1 chorobie |
| JPH1junctophilin 1 | Zawsze | W 1 chorobie |
| KAT5lysine acetyltransferase 5 | Zawsze | W 1 chorobie |
| KAT6Blysine acetyltransferase 6B | Zawsze | W 4 chorobach |
| KDM6Alysine demethylase 6A | Zawsze | W 2 chorobach |
| KDM6Blysine demethylase 6B | Zawsze | W 1 chorobie |
| KMT2Dlysine methyltransferase 2D | Zawsze | W 2 chorobach |
| LARGE1LARGE xylosyl- and glucuronyltransferase 1 | Zawsze | W 3 chorobach |
| LEF1lymphoid enhancer binding factor 1 | Zawsze | W 1 chorobie |
| LIG4DNA ligase 4 | Zawsze | W 2 chorobach |
| MAU2MAU2 sister chromatid cohesion factor | Zawsze | W 2 chorobach |
| MED16mediator complex subunit 16 | Zawsze | W 1 chorobie |
| MRPS28mitochondrial ribosomal protein S28 | Zawsze | W 1 chorobie |
| MSL2MSL complex subunit 2 | Zawsze | W 1 chorobie |
| MUSKmuscle associated receptor tyrosine kinase | Zawsze | W 2 chorobach |
| MYMKmyomaker, myoblast fusion factor | Zawsze | W 1 chorobie |
| MYRFmyelin regulatory factor | Zawsze | W 1 chorobie |
| NAF1nuclear assembly factor 1 ribonucleoprotein | Zawsze | W 1 chorobie |
| NALCNsodium leak channel, non-selective | Zawsze | W 2 chorobach |
| NDNFneuron derived neurotrophic factor | Zawsze | W 2 chorobach |
| NDUFB7NADH:ubiquinone oxidoreductase subunit B7 | Zawsze | W 1 chorobie |
| NOS3nitric oxide synthase 3 | Zawsze | W 1 chorobie |
| NSD1nuclear receptor binding SET domain protein 1 | Zawsze | W 3 chorobach |
| NUP88nucleoporin 88 | Zawsze | W 2 chorobach |
| ORC6origin recognition complex subunit 6 | Zawsze | W 2 chorobach |
| OTX2orthodenticle homeobox 2 | Zawsze | W 2 chorobach |
| PLVAPplasmalemma vesicle associated protein | Zawsze | W 1 chorobie |
| POLD1DNA polymerase delta 1, catalytic subunit | Zawsze | W 1 chorobie |
| POLR1ARNA polymerase I subunit A | Zawsze | W 1 chorobie |
| POLR3ARNA polymerase III subunit A | Zawsze | W 2 chorobach |
| POLR3KRNA polymerase III subunit K | Zawsze | W 1 chorobie |
| POMT1protein O-mannosyltransferase 1 | Zawsze | W 3 chorobach |
| POMT2protein O-mannosyltransferase 2 | Zawsze | W 4 chorobach |
| PRDM13PR/SET domain 13 | Zawsze | W 1 chorobie |
| PRPS1phosphoribosyl pyrophosphate synthetase 1 | Zawsze | W 1 chorobie |
| PSMC1proteasome 26S subunit, ATPase 1 | Zawsze | W 1 chorobie |
| PTDSS1phosphatidylserine synthase 1 | Zawsze | W 2 chorobach |
| PUM1pumilio RNA binding family member 1 | Zawsze | W 1 chorobie |
| PYCR1pyrroline-5-carboxylate reductase 1 | Zawsze | W 1 chorobie |
| RAB3GAP2RAB3 GTPase activating non-catalytic protein subunit 2 | Zawsze | W 4 chorobach |
| RAPSNreceptor associated protein of the synapse | Zawsze | W 2 chorobach |
| RNU6ATACRNA, U6atac small nuclear | Zawsze | W 1 chorobie |
| ROBO1roundabout guidance receptor 1 | Zawsze | W 2 chorobach |
| RPL10ribosomal protein L10 | Zawsze | W 3 chorobach |
| SCYL2SCY1 like pseudokinase 2 | Zawsze | W 1 chorobie |
| SLC25A24solute carrier family 25 member 24 | Zawsze | W 1 chorobie |
| SOS2SOS Ras/Rho guanine nucleotide exchange factor 2 | Zawsze | W 2 chorobach |
| SOX10SRY-box transcription factor 10 | Zawsze | W 4 chorobach |
| STT3BSTT3 oligosaccharyltransferase complex catalytic subunit B | Zawsze | W 2 chorobach |
| SYNE1spectrin repeat containing nuclear envelope protein 1 | Zawsze | W 2 chorobach |
| TAF4TATA-box binding protein associated factor 4 | Zawsze | W 1 chorobie |
| TASP1taspase 1 | Zawsze | W 1 chorobie |
| TBC1D20TBC1 domain family member 20 | Zawsze | W 2 chorobach |
| TBL1XR1TBL1X/Y related 1 | Zawsze | W 2 chorobach |
| UBR5ubiquitin protein ligase E3 component n-recognin 5 | Zawsze | W 1 chorobie |
| UGGT1UDP-glucose glycoprotein glucosyltransferase 1 | Zawsze | W 1 chorobie |
| UNC13Aunc-13 homolog A | Zawsze | W 1 chorobie |
| UQCC2ubiquinol-cytochrome c reductase complex assembly factor 2 | Zawsze | W 1 chorobie |
| VPS35LVPS35 endosomal protein sorting factor like | Zawsze | W 1 chorobie |
| XRCC4X-ray repair cross complementing 4 | Zawsze | W 1 chorobie |
| ZFPM2zinc finger protein, FOG family member 2 | Zawsze | W 3 chorobach |
| ZMYM3zinc finger MYM-type containing 3 | Zawsze | W 1 chorobie |
| ALX4ALX homeobox 4 | Bardzo często (80–99%) | W 1 chorobie |
| AMHanti-Mullerian hormone | Bardzo często (80–99%) | W 1 chorobie |
| AMHR2anti-Mullerian hormone receptor type 2 | Bardzo często (80–99%) | W 1 chorobie |
| ANK1ankyrin 1 | Bardzo często (80–99%) | W 1 chorobie |
| ANKRD11ankyrin repeat domain 11 | Bardzo często (80–99%) | W 3 chorobach |
| AP1S2adaptor related protein complex 1 subunit sigma 2 | Bardzo często (80–99%) | W 1 chorobie |
| ARXaristaless related homeobox | Bardzo często (80–99%) | W 2 chorobach |
| ATP6V0A2ATPase H+ transporting V0 subunit a2 | Bardzo często (80–99%) | W 2 chorobach |
| ATRXATRX chromatin remodeler | Bardzo często (80–99%) | W 3 chorobach |
| B4GALT7beta-1,4-galactosyltransferase 7 | Bardzo często (80–99%) | W 1 chorobie |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Bardzo często (80–99%) | W 5 chorobach |
| CD96CD96 molecule | Bardzo często (80–99%) | W 2 chorobach |
| CDC45cell division cycle 45 | Bardzo często (80–99%) | W 2 chorobach |
| CDKN1Ccyclin dependent kinase inhibitor 1C | Bardzo często (80–99%) | W 4 chorobach |
| CDT1chromatin licensing and DNA replication factor 1 | Bardzo często (80–99%) | W 2 chorobach |
| CHD7chromodomain helicase DNA binding protein 7 | Bardzo często (80–99%) | W 6 chorobach |
| CHRM3cholinergic receptor muscarinic 3 | Bardzo często (80–99%) | W 2 chorobach |
| CHST14carbohydrate sulfotransferase 14 | Bardzo często (80–99%) | W 2 chorobach |
| CKAP2Lcytoskeleton associated protein 2L | Bardzo często (80–99%) | W 2 chorobach |
| CYP11A1cytochrome P450 family 11 subfamily A member 1 | Bardzo często (80–99%) | W 2 chorobach |
| CYP19A1cytochrome P450 family 19 subfamily A member 1 | Bardzo często (80–99%) | W 1 chorobie |
| DNAJC19DnaJ heat shock protein family (Hsp40) member C19 | Bardzo często (80–99%) | W 1 chorobie |
| DSEdermatan sulfate epimerase | Bardzo często (80–99%) | W 1 chorobie |
| DUSP6dual specificity phosphatase 6 | Bardzo często (80–99%) | W 3 chorobach |
| DVL1dishevelled segment polarity protein 1 | Bardzo często (80–99%) | W 3 chorobach |
| EIF2S3eukaryotic translation initiation factor 2 subunit gamma | Bardzo często (80–99%) | W 1 chorobie |
| EMX2empty spiracles homeobox 2 | Bardzo często (80–99%) | W 2 chorobach |
| FGF17fibroblast growth factor 17 | Bardzo często (80–99%) | W 3 chorobach |
| FGF8fibroblast growth factor 8 | Bardzo często (80–99%) | W 4 chorobach |
| FGFR1fibroblast growth factor receptor 1 | Bardzo często (80–99%) | W 9 chorobach |
| FMR1fragile X messenger ribonucleoprotein 1 | Bardzo często (80–99%) | W 1 chorobie |
| FZD2frizzled class receptor 2 | Bardzo często (80–99%) | W 3 chorobach |
| GATA1GATA binding protein 1 | Bardzo często (80–99%) | W 1 chorobie |
| GMNNgeminin DNA replication inhibitor | Bardzo często (80–99%) | W 2 chorobach |
| GNRH1gonadotropin releasing hormone 1 | Bardzo często (80–99%) | W 3 chorobach |
| GNRHRgonadotropin releasing hormone receptor | Bardzo często (80–99%) | W 2 chorobach |
| GPC3glypican 3 | Bardzo często (80–99%) | W 3 chorobach |
| GPC4glypican 4 | Bardzo często (80–99%) | W 1 chorobie |
| HDAC8histone deacetylase 8 | Bardzo często (80–99%) | W 3 chorobach |
| HERC2HECT and RLD domain containing E3 ubiquitin protein ligase 2 | Bardzo często (80–99%) | W 1 chorobie |
| HS6ST1heparan sulfate 6-O-sulfotransferase 1 | Bardzo często (80–99%) | W 4 chorobach |
| HSD17B3hydroxysteroid 17-beta dehydrogenase 3 | Bardzo często (80–99%) | W 1 chorobie |
| HYMAIhydatidiform mole associated and imprinted | Bardzo często (80–99%) | W 1 chorobie |
| KDM5Clysine demethylase 5C | Bardzo często (80–99%) | W 2 chorobach |
| KISS1KiSS-1 metastasis suppressor | Bardzo często (80–99%) | W 2 chorobach |
| KISS1RKISS1 receptor | Bardzo często (80–99%) | W 3 chorobach |
| LAS1LLAS1 like ribosome biogenesis factor | Bardzo często (80–99%) | W 2 chorobach |
| MAB21L1mab-21 like 1 | Bardzo często (80–99%) | W 1 chorobie |
| MADDMAP kinase activating death domain | Bardzo często (80–99%) | W 2 chorobach |
| MAGEL2MAGE family member L2 | Bardzo często (80–99%) | W 7 chorobach |
| MAP2K1mitogen-activated protein kinase kinase 1 | Bardzo często (80–99%) | W 2 chorobach |
| MBTPS2membrane bound transcription factor peptidase, site 2 | Bardzo często (80–99%) | W 3 chorobach |
| MECP2methyl-CpG binding protein 2 | Bardzo często (80–99%) | W 2 chorobach |
| MEGF8multiple EGF like domains 8 | Bardzo często (80–99%) | W 2 chorobach |
| MKRN3makorin ring finger protein 3 | Bardzo często (80–99%) | W 1 chorobie |
| NDNnecdin, MAGE family member | Bardzo często (80–99%) | W 3 chorobach |
| NHLH2nescient helix-loop-helix 2 | Bardzo często (80–99%) | W 1 chorobie |
| NPAP1nuclear pore associated protein 1 | Bardzo często (80–99%) | W 1 chorobie |
| NR5A1nuclear receptor subfamily 5 group A member 1 | Bardzo często (80–99%) | W 2 chorobach |
| NSMFNMDA receptor synaptonuclear signaling and neuronal migration factor | Bardzo często (80–99%) | W 2 chorobach |
| OCA2OCA2 melanosomal transmembrane protein | Bardzo często (80–99%) | W 3 chorobach |
| ORC1origin recognition complex subunit 1 | Bardzo często (80–99%) | W 2 chorobach |
| ORC4origin recognition complex subunit 4 | Bardzo często (80–99%) | W 1 chorobie |
| PHF6PHD finger protein 6 | Bardzo często (80–99%) | W 2 chorobach |
| PLAGL1PLAG1 like zinc finger 1 | Bardzo często (80–99%) | W 1 chorobie |
| POLA1DNA polymerase alpha 1, catalytic subunit | Bardzo często (80–99%) | W 1 chorobie |
| POLEDNA polymerase epsilon, catalytic subunit | Bardzo często (80–99%) | W 1 chorobie |
| PROK2prokineticin 2 | Bardzo często (80–99%) | W 4 chorobach |
| PROKR2prokineticin receptor 2 | Bardzo często (80–99%) | W 6 chorobach |
| PTPN11protein tyrosine phosphatase non-receptor type 11 | Bardzo często (80–99%) | W 4 chorobach |
| PWAR1Prader Willi/Angelman region RNA 1 | Bardzo często (80–99%) | W 1 chorobie |
| PWRN1Prader-Willi region non-protein coding RNA 1 | Bardzo często (80–99%) | W 1 chorobie |
| RAB18RAB18, member RAS oncogene family | Bardzo często (80–99%) | W 1 chorobie |
| RAB23RAB23, member RAS oncogene family | Bardzo często (80–99%) | W 2 chorobach |
| RAB3GAP1RAB3 GTPase activating protein catalytic subunit 1 | Bardzo często (80–99%) | W 3 chorobach |
| SEMA3Esemaphorin 3E | Bardzo często (80–99%) | W 2 chorobach |
| SIM1SIM bHLH transcription factor 1 | Bardzo często (80–99%) | W 1 chorobie |
| SNORD115-1small nucleolar RNA, C/D box 115-1 | Bardzo często (80–99%) | W 1 chorobie |
| SNORD116-1small nucleolar RNA, C/D box 116-1 | Bardzo często (80–99%) | W 1 chorobie |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Bardzo często (80–99%) | W 3 chorobach |
| SOX9SRY-box transcription factor 9 | Bardzo często (80–99%) | W 2 chorobach |
| SPRY4sprouty RTK signaling antagonist 4 | Bardzo często (80–99%) | W 3 chorobach |
| SRD5A2steroid 5 alpha-reductase 2 | Bardzo często (80–99%) | W 2 chorobach |
| SRYsex determining region Y | Bardzo często (80–99%) | W 3 chorobach |
| TAC3tachykinin precursor 3 | Bardzo często (80–99%) | W 2 chorobach |
| TACR3tachykinin receptor 3 | Bardzo często (80–99%) | W 4 chorobach |
| TCF12transcription factor 12 | Bardzo często (80–99%) | W 1 chorobie |
| TOE1target of EGR1, exonuclease | Bardzo często (80–99%) | W 2 chorobach |
| TSPYL1TSPY like 1 | Bardzo często (80–99%) | W 2 chorobach |
| UBR7ubiquitin protein ligase E3 component n-recognin 7 | Bardzo często (80–99%) | W 1 chorobie |
| WDR11WD repeat domain 11 | Bardzo często (80–99%) | W 5 chorobach |
| ABCD4ATP binding cassette subfamily D member 4 | Często (30–79%) | W 1 chorobie |
| ACTA2actin alpha 2, smooth muscle | Często (30–79%) | W 1 chorobie |
| ADAMTS15ADAM metallopeptidase with thrombospondin type 1 motif 15 | Często (30–79%) | W 1 chorobie |
| AEBP1AE binding protein 1 | Często (30–79%) | W 2 chorobach |
| AHDC1AT-hook DNA binding motif containing 1 | Często (30–79%) | W 1 chorobie |
| ALDH1A2aldehyde dehydrogenase 1 family member A2 | Często (30–79%) | W 1 chorobie |
| ALG8ALG8 alpha-1,3-glucosyltransferase | Często (30–79%) | W 1 chorobie |
| ANAPC1anaphase promoting complex subunit 1 | Często (30–79%) | W 1 chorobie |
| ANOS1anosmin 1 | Często (30–79%) | W 3 chorobach |
| ARCN1archain 1 coat protein complex I subunit delta | Często (30–79%) | W 1 chorobie |
| ARID1BAT-rich interaction domain 1B | Często (30–79%) | W 2 chorobach |
| ARID2AT-rich interaction domain 2 | Często (30–79%) | W 1 chorobie |
| ATN1atrophin 1 | Często (30–79%) | W 1 chorobie |
| ATP6V1AATPase H+ transporting V1 subunit A | Często (30–79%) | W 1 chorobie |
| B3GALNT2beta-1,3-N-acetylgalactosaminyltransferase 2 | Często (30–79%) | W 1 chorobie |
| B3GLCTbeta 3-glucosyltransferase | Często (30–79%) | W 2 chorobach |
| B4GAT1beta-1,4-glucuronyltransferase 1 | Często (30–79%) | W 1 chorobie |
| B9D1B9 domain containing 1 | Często (30–79%) | W 1 chorobie |
| B9D2B9 domain containing 2 | Często (30–79%) | W 1 chorobie |
| BCORBCL6 corepressor | Często (30–79%) | W 3 chorobach |
| BDNFbrain derived neurotrophic factor | Często (30–79%) | W 1 chorobie |
| BRD4bromodomain containing 4 | Często (30–79%) | W 1 chorobie |
| BRF1BRF1 general transcription factor IIIB subunit | Często (30–79%) | W 2 chorobach |
| BRPF1bromodomain and PHD finger containing 1 | Często (30–79%) | W 1 chorobie |
| CAMSAP1calmodulin regulated spectrin associated protein 1 | Często (30–79%) | W 1 chorobie |
| CBLCbl proto-oncogene | Często (30–79%) | W 2 chorobach |
| CC2D2Acoiled-coil and C2 domain containing 2A | Często (30–79%) | W 1 chorobie |
| CCDC141coiled-coil domain containing 141 | Często (30–79%) | W 2 chorobach |
| CCDC22CCC complex scaffolding subunit CCDC22 | Często (30–79%) | W 1 chorobie |
| CDC42BPBCDC42 binding protein kinase beta | Często (30–79%) | W 1 chorobie |
| CDH2cadherin 2 | Często (30–79%) | W 1 chorobie |
| CEP152centrosomal protein 152 | Często (30–79%) | W 1 chorobie |
| CEP290centrosomal protein 290 | Często (30–79%) | W 2 chorobach |
| CHD4chromodomain helicase DNA binding protein 4 | Często (30–79%) | W 1 chorobie |
| CITED2Cbp/p300 interacting transactivator with ED-rich tail 2 | Często (30–79%) | W 1 chorobie |
| CLCN3Cl-/H+ antiporter 3 | Często (30–79%) | W 1 chorobie |
| COG1component of oligomeric golgi complex 1 | Często (30–79%) | W 1 chorobie |
| COL4A1collagen type IV alpha 1 chain | Często (30–79%) | W 1 chorobie |
| COLEC10collectin subfamily member 10 | Często (30–79%) | W 1 chorobie |
| CPEcarboxypeptidase E | Często (30–79%) | W 1 chorobie |
| CPLX1complexin 1 | Często (30–79%) | W 2 chorobach |
| CREBBPCREB binding lysine acetyltransferase | Często (30–79%) | W 5 chorobach |
| CRPPACDP-L-ribitol pyrophosphorylase A | Często (30–79%) | W 1 chorobie |
| CSPP1centrosome and spindle pole associated protein 1 | Często (30–79%) | W 1 chorobie |
| CTBP1C-terminal binding protein 1 | Często (30–79%) | W 2 chorobach |
| CTCFCCCTC-binding factor | Często (30–79%) | W 2 chorobach |
| CYB5Acytochrome b5 type A | Często (30–79%) | W 1 chorobie |
| CYP17A1cytochrome P450 family 17 subfamily A member 1 | Często (30–79%) | W 1 chorobie |
| DACT1dishevelled binding antagonist of beta catenin 1 | Często (30–79%) | W 1 chorobie |
| DAG1dystroglycan 1 | Często (30–79%) | W 1 chorobie |
| DCCDCC netrin 1 receptor | Często (30–79%) | W 1 chorobie |
| DDB2damage specific DNA binding protein 2 | Często (30–79%) | W 1 chorobie |
| DDX3XDEAD-box helicase 3 X-linked | Często (30–79%) | W 1 chorobie |
| DDX6DEAD-box helicase 6 | Często (30–79%) | W 1 chorobie |
| DHCR77-dehydrocholesterol reductase | Często (30–79%) | W 2 chorobach |
| DHX37DEAH-box helicase 37 | Często (30–79%) | W 1 chorobie |
| DIS3L2DIS3 like 3'-5' exoribonuclease 2 | Często (30–79%) | W 3 chorobach |
| DNA2DNA replication helicase/nuclease 2 | Często (30–79%) | W 1 chorobie |
| DOK7docking protein 7 | Często (30–79%) | W 1 chorobie |
| DPF2double PHD fingers 2 | Często (30–79%) | W 1 chorobie |
| DPYSL5dihydropyrimidinase like 5 | Często (30–79%) | W 1 chorobie |
| DTYMKdeoxythymidylate kinase | Często (30–79%) | W 1 chorobie |
| DYNC2H1dynein cytoplasmic 2 heavy chain 1 | Często (30–79%) | W 1 chorobie |
| DYNC2I1dynein 2 intermediate chain 1 | Często (30–79%) | W 1 chorobie |
| DYNC2I2dynein 2 intermediate chain 2 | Często (30–79%) | W 2 chorobach |
| DYNC2LI1dynein cytoplasmic 2 light intermediate chain 1 | Często (30–79%) | W 1 chorobie |
| EBPEBP cholestenol delta-isomerase | Często (30–79%) | W 2 chorobach |
| EHMT1euchromatic histone lysine methyltransferase 1 | Często (30–79%) | W 2 chorobach |
| EIF5Aeukaryotic translation initiation factor 5A | Często (30–79%) | W 1 chorobie |
| EMG1EMG1 N1-specific pseudouridine methyltransferase | Często (30–79%) | W 1 chorobie |
| EP300EP300 lysine acetyltransferase | Często (30–79%) | W 2 chorobach |
| ERCC2ERCC excision repair 2, TFIIH core complex helicase subunit | Często (30–79%) | W 2 chorobach |
| ERCC3ERCC excision repair 3, TFIIH core complex helicase subunit | Często (30–79%) | W 2 chorobach |
| ERCC4ERCC excision repair 4, endonuclease catalytic subunit | Często (30–79%) | W 3 chorobach |
| ERCC5ERCC excision repair 5, endonuclease | Często (30–79%) | W 1 chorobie |
| ESCO2establishment of sister chromatid cohesion N-acetyltransferase 2 | Często (30–79%) | W 2 chorobach |
| EVCEvC ciliary complex subunit 1 | Często (30–79%) | W 2 chorobach |
| EVC2EvC ciliary complex subunit 2 | Często (30–79%) | W 2 chorobach |
| FANCFFA complementation group F | Często (30–79%) | W 2 chorobach |
| FBLN1fibulin 1 | Często (30–79%) | W 1 chorobie |
| FBXO22F-box protein 22 | Często (30–79%) | W 1 chorobie |
| FGD1FYVE, RhoGEF and PH domain containing 1 | Często (30–79%) | W 1 chorobie |
| FGFR2fibroblast growth factor receptor 2 | Często (30–79%) | W 4 chorobach |
| FGFRL1fibroblast growth factor receptor like 1 | Często (30–79%) | W 1 chorobie |
| FILIP1filamin A interacting protein 1 | Często (30–79%) | W 1 chorobie |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Często (30–79%) | W 2 chorobach |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Często (30–79%) | W 1 chorobie |
| FLNBfilamin B | Często (30–79%) | W 4 chorobach |
| FLRT3fibronectin leucine rich transmembrane protein 3 | Często (30–79%) | W 2 chorobach |
| FLT4fms related receptor tyrosine kinase 4 | Często (30–79%) | W 1 chorobie |
| FXR1FMR1 autosomal homolog 1 | Często (30–79%) | W 2 chorobach |
| G6PC3glucose-6-phosphatase catalytic subunit 3 | Często (30–79%) | W 1 chorobie |
| GATA5GATA binding protein 5 | Często (30–79%) | W 1 chorobie |
| GATA6GATA binding protein 6 | Często (30–79%) | W 1 chorobie |
| GDF1growth differentiation factor 1 | Często (30–79%) | W 1 chorobie |
| GJA5gap junction protein alpha 5 | Często (30–79%) | W 1 chorobie |
| GLDNgliomedin | Często (30–79%) | W 1 chorobie |
| GLI1GLI family zinc finger 1 | Często (30–79%) | W 1 chorobie |
| GPC6glypican 6 | Często (30–79%) | W 2 chorobach |
| HBA1hemoglobin subunit alpha 1 | Często (30–79%) | W 1 chorobie |
| HBA2hemoglobin subunit alpha 2 | Często (30–79%) | W 1 chorobie |
| HESX1HESX homeobox 1 | Często (30–79%) | W 3 chorobach |
| HNRNPH1heterogeneous nuclear ribonucleoprotein H1 | Często (30–79%) | W 1 chorobie |
| HNRNPRheterogeneous nuclear ribonucleoprotein R | Często (30–79%) | W 1 chorobie |
| HPSE2heparanase 2 (inactive) | Często (30–79%) | W 2 chorobach |
| HRASHRas proto-oncogene, GTPase | Często (30–79%) | W 2 chorobach |
| HS2ST1heparan sulfate 2-O-sulfotransferase 1 | Często (30–79%) | W 1 chorobie |
| HSD3B2hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | Często (30–79%) | W 2 chorobach |
| HSPG2heparan sulfate proteoglycan 2 | Często (30–79%) | W 3 chorobach |
| HUWE1HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 | Często (30–79%) | W 1 chorobie |
| IFT80intraflagellar transport 80 | Często (30–79%) | W 1 chorobie |
| IL17RDinterleukin 17 receptor D | Często (30–79%) | W 1 chorobie |
| INPPL1inositol polyphosphate phosphatase like 1 | Często (30–79%) | W 1 chorobie |
| IRF6interferon regulatory factor 6 | Często (30–79%) | W 2 chorobach |
| JAG1jagged canonical Notch ligand 1 | Często (30–79%) | W 1 chorobie |
| JAM3junctional adhesion molecule 3 | Często (30–79%) | W 1 chorobie |
| KANSL1KAT8 regulatory NSL complex subunit 1 | Często (30–79%) | W 1 chorobie |
| KCNK3potassium two pore domain channel subfamily K member 3 | Często (30–79%) | W 1 chorobie |
| KDM1Alysine demethylase 1A | Często (30–79%) | W 2 chorobach |
| KDM5Blysine demethylase 5B | Często (30–79%) | W 1 chorobie |
| KDRkinase insert domain receptor | Często (30–79%) | W 1 chorobie |
| KIF21Akinesin family member 21A | Często (30–79%) | W 1 chorobie |
| KRASKRas proto-oncogene, GTPase | Często (30–79%) | W 3 chorobach |
| LETM1leucine zipper and EF-hand containing transmembrane protein 1 | Często (30–79%) | W 2 chorobach |
| LMNB2lamin B2 | Często (30–79%) | W 1 chorobie |
| LONP1lon peptidase 1, mitochondrial | Często (30–79%) | W 1 chorobie |
| LRIG2leucine rich repeats and immunoglobulin like domains 2 | Często (30–79%) | W 1 chorobie |
| LZTR1leucine zipper like post translational regulator 1 | Często (30–79%) | W 3 chorobach |
| MAFMAF bZIP transcription factor | Często (30–79%) | W 1 chorobie |
| MAMLD1mastermind like domain containing 1 | Często (30–79%) | W 2 chorobach |
| MAP2K2mitogen-activated protein kinase kinase 2 | Często (30–79%) | W 2 chorobach |
| MAP3K1mitogen-activated protein kinase kinase kinase 1 | Często (30–79%) | W 1 chorobie |
| MAPK1mitogen-activated protein kinase 1 | Często (30–79%) | W 1 chorobie |
| MCTP2multiple C2 and transmembrane domain containing 2 | Często (30–79%) | W 1 chorobie |
| MED11mediator complex subunit 11 | Często (30–79%) | W 1 chorobie |
| MED12mediator complex subunit 12 | Często (30–79%) | W 3 chorobach |
| MKKSMKKS centrosomal shuttling protein | Często (30–79%) | W 3 chorobach |
| MKS1MKS transition zone complex subunit 1 | Często (30–79%) | W 3 chorobach |
| MRASmuscle RAS oncogene homolog | Często (30–79%) | W 1 chorobie |
| MTM1myotubularin 1 | Często (30–79%) | W 2 chorobach |
| MYH3myosin heavy chain 3 | Często (30–79%) | W 3 chorobach |
| MYL11myosin light chain 11 | Często (30–79%) | W 1 chorobie |
| MYOD1myogenic differentiation 1 | Często (30–79%) | W 1 chorobie |
| NAA10N-alpha-acetyltransferase 10, NatA catalytic subunit | Często (30–79%) | W 4 chorobach |
| NEDD4LNEDD4 like E3 ubiquitin protein ligase | Często (30–79%) | W 1 chorobie |
| NELFAnegative elongation factor complex member A | Często (30–79%) | W 1 chorobie |
| NF1neurofibromin 1 | Często (30–79%) | W 2 chorobach |
| NFIXnuclear factor I X | Często (30–79%) | W 1 chorobie |
| NIPBLNIPBL cohesin loading factor | Często (30–79%) | W 2 chorobach |
| NKAPNFKB activating protein | Często (30–79%) | W 1 chorobie |
| NKX2-5NK2 homeobox 5 | Często (30–79%) | W 1 chorobie |
| NKX2-6NK2 homeobox 6 | Często (30–79%) | W 1 chorobie |
| NONOnon-POU domain containing octamer binding | Często (30–79%) | W 2 chorobach |
| NOTCH3notch receptor 3 | Często (30–79%) | W 3 chorobach |
| NR0B1nuclear receptor subfamily 0 group B member 1 | Często (30–79%) | W 2 chorobach |
| NRASNRAS proto-oncogene, GTPase | Często (30–79%) | W 3 chorobach |
| NSD2nuclear receptor binding SET domain protein 2 | Często (30–79%) | W 2 chorobach |
| NXNnucleoredoxin | Często (30–79%) | W 1 chorobie |
| OCRLOCRL inositol polyphosphate-5-phosphatase | Często (30–79%) | W 2 chorobach |
| ODC1ornithine decarboxylase 1 | Często (30–79%) | W 1 chorobie |
| PACS1phosphofurin acidic cluster sorting protein 1 | Często (30–79%) | W 2 chorobach |
| PACS2phosphofurin acidic cluster sorting protein 2 | Często (30–79%) | W 1 chorobie |
| PAX6paired box 6 | Często (30–79%) | W 2 chorobach |
| PAX7paired box 7 | Często (30–79%) | W 1 chorobie |
| PDE4Dphosphodiesterase 4D | Często (30–79%) | W 3 chorobach |
| PEX1peroxisomal biogenesis factor 1 | Często (30–79%) | W 2 chorobach |
| PEX10peroxisomal biogenesis factor 10 | Często (30–79%) | W 1 chorobie |
| PEX11Bperoxisomal biogenesis factor 11 beta | Często (30–79%) | W 1 chorobie |
| PEX12peroxisomal biogenesis factor 12 | Często (30–79%) | W 1 chorobie |
| PEX13peroxisomal biogenesis factor 13 | Często (30–79%) | W 1 chorobie |
| PEX14peroxisomal biogenesis factor 14 | Często (30–79%) | W 1 chorobie |
| PEX16peroxisomal biogenesis factor 16 | Często (30–79%) | W 1 chorobie |
| PEX19peroxisomal biogenesis factor 19 | Często (30–79%) | W 1 chorobie |
| PEX2peroxisomal biogenesis factor 2 | Często (30–79%) | W 2 chorobach |
| PEX26peroxisomal biogenesis factor 26 | Często (30–79%) | W 1 chorobie |
| PEX3peroxisomal biogenesis factor 3 | Często (30–79%) | W 1 chorobie |
| PEX5peroxisomal biogenesis factor 5 | Często (30–79%) | W 2 chorobach |
| PEX6peroxisomal biogenesis factor 6 | Często (30–79%) | W 1 chorobie |
| PHACTR1phosphatase and actin regulator 1 | Często (30–79%) | W 1 chorobie |
| PHF8PHD finger protein 8 | Często (30–79%) | W 1 chorobie |
| PIGGphosphatidylinositol glycan anchor biosynthesis class G (EMM blood group) | Często (30–79%) | W 1 chorobie |
| PIGNphosphatidylinositol glycan anchor biosynthesis class N | Często (30–79%) | W 1 chorobie |
| PIK3C2Aphosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha | Często (30–79%) | W 1 chorobie |
| PNPLA6patatin like domain 6, lysophospholipase | Często (30–79%) | W 3 chorobach |
| POGZpogo transposable element derived with ZNF domain | Często (30–79%) | W 1 chorobie |
| POMGNT1protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) | Często (30–79%) | W 1 chorobie |
| POMGNT2protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-) | Często (30–79%) | W 1 chorobie |
| POMKprotein O-mannose kinase | Często (30–79%) | W 1 chorobie |
| PPFIA3PPFI scaffold protein A3 | Często (30–79%) | W 1 chorobie |
| PPFIBP1PPFIB scaffold protein 1 | Często (30–79%) | W 1 chorobie |
| PPP1CBprotein phosphatase 1 catalytic subunit beta | Często (30–79%) | W 2 chorobach |
| PPP1R12Aprotein phosphatase 1 regulatory subunit 12A | Często (30–79%) | W 1 chorobie |
| PRIM1DNA primase subunit 1 | Często (30–79%) | W 1 chorobie |
| PRKACAprotein kinase cAMP-activated catalytic subunit alpha | Często (30–79%) | W 1 chorobie |
| PRKACBprotein kinase cAMP-activated catalytic subunit beta | Często (30–79%) | W 1 chorobie |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Często (30–79%) | W 2 chorobach |
| PRMT7protein arginine methyltransferase 7 | Często (30–79%) | W 1 chorobie |
| PSMD12proteasome 26S subunit, non-ATPase 12 | Często (30–79%) | W 1 chorobie |
| PTPRFprotein tyrosine phosphatase receptor type F | Często (30–79%) | W 1 chorobie |
| RAD21RAD21 cohesin complex component | Często (30–79%) | W 1 chorobie |
| RAD51CRAD51 paralog C | Często (30–79%) | W 2 chorobach |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Często (30–79%) | W 4 chorobach |
| RASA2RAS p21 protein activator 2 | Często (30–79%) | W 1 chorobie |
| RIN2Ras and Rab interactor 2 | Często (30–79%) | W 2 chorobach |
| RIT1Ras like without CAAX 1 | Często (30–79%) | W 2 chorobach |
| RNU4ATACRNA, U4atac small nuclear | Często (30–79%) | W 2 chorobach |
| ROR2ROR family WNT receptor 2 | Często (30–79%) | W 2 chorobach |
| RPGRIP1RPGR interacting protein 1 | Często (30–79%) | W 1 chorobie |
| RPGRIP1LRPGRIP1 like | Często (30–79%) | W 1 chorobie |
| RRASRAS related | Często (30–79%) | W 1 chorobie |
| RRAS2RAS related 2 | Często (30–79%) | W 1 chorobie |
| RSPO2R-spondin 2 | Często (30–79%) | W 1 chorobie |
| RXYLT1ribitol xylosyltransferase 1 | Często (30–79%) | W 1 chorobie |
| RYR1ryanodine receptor 1 | Często (30–79%) | W 3 chorobach |
| SALL1spalt like transcription factor 1 | Często (30–79%) | W 2 chorobach |
| SAMD9sterile alpha motif domain containing 9 | Często (30–79%) | W 1 chorobie |
| SEC23ASEC23 homolog A, COPII component | Często (30–79%) | W 1 chorobie |
| SEMA3Asemaphorin 3A | Często (30–79%) | W 3 chorobach |
| SETD5SET domain containing 5 | Często (30–79%) | W 1 chorobie |
| SHOC2SHOC2 leucine rich repeat scaffold protein | Często (30–79%) | W 2 chorobach |
| SIAH1siah E3 ubiquitin protein ligase 1 | Często (30–79%) | W 1 chorobie |
| SLC18A3solute carrier family 18 member A3 | Często (30–79%) | W 1 chorobie |
| SLC30A7solute carrier family 30 member 7 | Często (30–79%) | W 1 chorobie |
| SLC35D1solute carrier family 35 member D1 | Często (30–79%) | W 1 chorobie |
| SMAD4SMAD family member 4 | Często (30–79%) | W 2 chorobach |
| SMARCA2SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2 | Często (30–79%) | W 3 chorobach |
| SMARCA4SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4 | Często (30–79%) | W 1 chorobie |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Często (30–79%) | W 1 chorobie |
| SMARCC2SWI/SNF related BAF chromatin remodeling complex subunit C2 | Często (30–79%) | W 2 chorobach |
| SMARCD1SWI/SNF related BAF chromatin remodeling complex subunit D1 | Często (30–79%) | W 1 chorobie |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Często (30–79%) | W 1 chorobie |
| SMC1Astructural maintenance of chromosomes 1A | Często (30–79%) | W 1 chorobie |
| SMC3structural maintenance of chromosomes 3 | Często (30–79%) | W 2 chorobach |
| SMCHD1structural maintenance of chromosomes flexible hinge domain containing 1 | Często (30–79%) | W 2 chorobach |
| SOS1SOS Ras/Rac guanine nucleotide exchange factor 1 | Często (30–79%) | W 2 chorobach |
| SOX11SRY-box transcription factor 11 | Często (30–79%) | W 1 chorobie |
| SOX2SRY-box transcription factor 2 | Często (30–79%) | W 3 chorobach |
| SOX3SRY-box transcription factor 3 | Często (30–79%) | W 1 chorobie |
| SOX4SRY-box transcription factor 4 | Często (30–79%) | W 1 chorobie |
| SPECC1Lsperm antigen with calponin homology and coiled-coil domains 1 like | Często (30–79%) | W 1 chorobie |
| SPRED2sprouty related EVH1 domain containing 2 | Często (30–79%) | W 2 chorobach |
| STAC3SH3 and cysteine rich domain 3 | Często (30–79%) | W 2 chorobach |
| STAG1STAG1 cohesin complex component | Często (30–79%) | W 2 chorobach |
| STT3ASTT3 oligosaccharyltransferase complex catalytic subunit A | Często (30–79%) | W 1 chorobie |
| SUZ12SUZ12 polycomb repressive complex 2 subunit | Często (30–79%) | W 2 chorobach |
| TBCKTBC1 domain containing kinase | Często (30–79%) | W 2 chorobach |
| TBX1T-box transcription factor 1 | Często (30–79%) | W 3 chorobach |
| TBX3T-box transcription factor 3 | Często (30–79%) | W 1 chorobie |
| TBX4T-box transcription factor 4 | Często (30–79%) | W 1 chorobie |
| TCTN1tectonic family member 1 | Często (30–79%) | W 1 chorobie |
| TCTN2tectonic family member 2 | Często (30–79%) | W 1 chorobie |
| TCTN3tectonic family member 3 | Często (30–79%) | W 1 chorobie |
| TDRD9tudor domain containing 9 | Często (30–79%) | W 1 chorobie |
| TIAM1TIAM Rac1 associated GEF 1 | Często (30–79%) | W 1 chorobie |
| TMEM107transmembrane protein 107 | Często (30–79%) | W 1 chorobie |
| TMEM216transmembrane protein 216 | Często (30–79%) | W 1 chorobie |
| TMEM231transmembrane protein 231 | Często (30–79%) | W 1 chorobie |
| TMEM237transmembrane protein 237 | Często (30–79%) | W 1 chorobie |
| TMEM67transmembrane protein 67 | Często (30–79%) | W 1 chorobie |
| TMEM70transmembrane protein 70 | Często (30–79%) | W 2 chorobach |
| TSHZ3teashirt zinc finger homeobox 3 | Często (30–79%) | W 1 chorobie |
| TTC5tetratricopeptide repeat domain 5 | Często (30–79%) | W 1 chorobie |
| TUBA1Atubulin alpha 1a | Często (30–79%) | W 1 chorobie |
| TWIST2twist family bHLH transcription factor 2 | Często (30–79%) | W 1 chorobie |
| TXNDC15thioredoxin domain containing 15 | Często (30–79%) | W 1 chorobie |
| USP7ubiquitin specific peptidase 7 | Często (30–79%) | W 2 chorobach |
| VAMP7vesicle associated membrane protein 7 | Często (30–79%) | W 1 chorobie |
| WBP4WW domain binding protein 4 | Często (30–79%) | W 1 chorobie |
| WDPCPWD repeat containing planar cell polarity effector | Często (30–79%) | W 2 chorobach |
| WDR35WD repeat domain 35 | Często (30–79%) | W 1 chorobie |
| WNT3Wnt family member 3 | Często (30–79%) | W 1 chorobie |
| WNT5AWnt family member 5A | Często (30–79%) | W 2 chorobach |
| WNT7AWnt family member 7A | Często (30–79%) | W 2 chorobach |
| WT1WT1 transcription factor | Często (30–79%) | W 5 chorobach |
| WWOXWW domain containing oxidoreductase | Często (30–79%) | W 1 chorobie |
| XPAXPA, DNA damage recognition and repair factor | Często (30–79%) | W 1 chorobie |
| XPCXPC complex subunit, DNA damage recognition and repair factor | Często (30–79%) | W 1 chorobie |
| ZBTB20zinc finger and BTB domain containing 20 | Często (30–79%) | W 1 chorobie |
| ZEB2zinc finger E-box binding homeobox 2 | Często (30–79%) | W 4 chorobach |
| ZFXzinc finger protein X-linked | Często (30–79%) | W 1 chorobie |
| ZSCAN10zinc finger and SCAN domain containing 10 | Często (30–79%) | W 1 chorobie |
| ZSWIM6zinc finger SWIM-type containing 6 | Często (30–79%) | W 2 chorobach |
| AARS1alanyl-tRNA synthetase 1 | Czasami (5–29%) | W 1 chorobie |
| ABL1ABL proto-oncogene 1, non-receptor tyrosine kinase | Czasami (5–29%) | W 1 chorobie |
| ACTG2actin gamma 2, smooth muscle | Czasami (5–29%) | W 1 chorobie |
| ADAT3adenosine deaminase tRNA specific 3 | Czasami (5–29%) | W 1 chorobie |
| ADNPactivity dependent neuroprotector homeobox | Czasami (5–29%) | W 2 chorobach |
| ALDH18A1aldehyde dehydrogenase 18 family member A1 | Czasami (5–29%) | W 1 chorobie |
| ALKBH8alkB homolog 8, tRNA methyltransferase | Czasami (5–29%) | W 1 chorobie |
| ARL6ARF like GTPase 6 | Czasami (5–29%) | W 1 chorobie |
| ARVCFARVCF delta catenin family member | Czasami (5–29%) | W 1 chorobie |
| ASXL3ASXL transcriptional regulator 3 | Czasami (5–29%) | W 1 chorobie |
| ATAD3AATPase family AAA domain containing 3A | Czasami (5–29%) | W 1 chorobie |
| AUTS2activator of transcription and developmental regulator AUTS2 | Czasami (5–29%) | W 1 chorobie |
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Czasami (5–29%) | W 1 chorobie |
| BBIP1BBSome interacting protein 1 | Czasami (5–29%) | W 1 chorobie |
| BBS1Bardet-Biedl syndrome 1 | Czasami (5–29%) | W 1 chorobie |
| BBS10Bardet-Biedl syndrome 10 | Czasami (5–29%) | W 1 chorobie |
| BBS12Bardet-Biedl syndrome 12 | Czasami (5–29%) | W 1 chorobie |
| BBS2Bardet-Biedl syndrome 2 | Czasami (5–29%) | W 1 chorobie |
| BBS5Bardet-Biedl syndrome 5 | Czasami (5–29%) | W 1 chorobie |
| BBS7Bardet-Biedl syndrome 7 | Czasami (5–29%) | W 1 chorobie |
| BBS9Bardet-Biedl syndrome 9 | Czasami (5–29%) | W 1 chorobie |
| BICRABRD4 interacting chromatin remodeling complex associated protein | Czasami (5–29%) | W 1 chorobie |
| BIN1bridging integrator 1 | Czasami (5–29%) | W 1 chorobie |
| BMP4bone morphogenetic protein 4 | Czasami (5–29%) | W 2 chorobach |
| BRCA1BRCA1 DNA repair associated | Czasami (5–29%) | W 1 chorobie |
| BRCA2BRCA2 DNA repair associated | Czasami (5–29%) | W 2 chorobach |
| BRIP1BRCA1 interacting DNA helicase 1 | Czasami (5–29%) | W 1 chorobie |
| BRWD3bromodomain and WD repeat domain containing 3 | Czasami (5–29%) | W 1 chorobie |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Czasami (5–29%) | W 1 chorobie |
| CAMK2Acalcium/calmodulin dependent protein kinase II alpha | Czasami (5–29%) | W 1 chorobie |
| CARS1cysteinyl-tRNA synthetase 1 | Czasami (5–29%) | W 1 chorobie |
| CASZ1castor zinc finger 1 | Czasami (5–29%) | W 1 chorobie |
| CDK8cyclin dependent kinase 8 | Czasami (5–29%) | W 1 chorobie |
| CDONcell adhesion associated, oncogene regulated | Czasami (5–29%) | W 1 chorobie |
| CEP19centrosomal protein 19 | Czasami (5–29%) | W 1 chorobie |
| CFAP418cilia and flagella associated protein 418 | Czasami (5–29%) | W 1 chorobie |
| CHD6chromodomain helicase DNA binding protein 6 | Czasami (5–29%) | W 1 chorobie |
| CILK1ciliogenesis associated kinase 1 | Czasami (5–29%) | W 1 chorobie |
| CLIP2CAP-Gly domain containing linker protein 2 | Czasami (5–29%) | W 1 chorobie |
| COG5component of oligomeric golgi complex 5 | Czasami (5–29%) | W 1 chorobie |
| COMTcatechol-O-methyltransferase | Czasami (5–29%) | W 1 chorobie |
| CTR9CTR9 component of Paf1/RNA polymerase II complex | Czasami (5–29%) | W 1 chorobie |
| CWC27CWC27 spliceosome associated cyclophilin | Czasami (5–29%) | W 1 chorobie |
| DAZ1deleted in azoospermia 1 | Czasami (5–29%) | W 1 chorobie |
| DAZ2deleted in azoospermia 2 | Czasami (5–29%) | W 1 chorobie |
| DAZ3deleted in azoospermia 3 | Czasami (5–29%) | W 1 chorobie |
| DAZ4deleted in azoospermia 4 | Czasami (5–29%) | W 1 chorobie |
| DBR1debranching RNA lariats 1 | Czasami (5–29%) | W 1 chorobie |
| DDX3YDEAD-box helicase 3 Y-linked | Czasami (5–29%) | W 1 chorobie |
| DGCR2DiGeorge syndrome critical region gene 2 | Czasami (5–29%) | W 1 chorobie |
| DGCR6DiGeorge syndrome critical region gene 6 | Czasami (5–29%) | W 1 chorobie |
| DGCR8DGCR8 microprocessor complex subunit | Czasami (5–29%) | W 1 chorobie |
| DLK1delta like non-canonical Notch ligand 1 | Czasami (5–29%) | W 2 chorobach |
| DLL3delta like canonical Notch ligand 3 | Czasami (5–29%) | W 1 chorobie |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Czasami (5–29%) | W 1 chorobie |
| DNM2dynamin 2 | Czasami (5–29%) | W 1 chorobie |
| DNMT3ADNA methyltransferase 3 alpha | Czasami (5–29%) | W 1 chorobie |
| DOT1LDOT1 like histone lysine methyltransferase | Czasami (5–29%) | W 1 chorobie |
| DPAGT1dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 | Czasami (5–29%) | W 1 chorobie |
| DPP9dipeptidyl peptidase 9 | Czasami (5–29%) | W 1 chorobie |
| DYRK1Adual specificity tyrosine phosphorylation regulated kinase 1A | Czasami (5–29%) | W 2 chorobach |
| EBF3EBF transcription factor 3 | Czasami (5–29%) | W 1 chorobie |
| EIF4Heukaryotic translation initiation factor 4H | Czasami (5–29%) | W 1 chorobie |
| ELNelastin | Czasami (5–29%) | W 1 chorobie |
| ESS2ess-2 spliceosome associated protein | Czasami (5–29%) | W 1 chorobie |
| EZH2enhancer of zeste 2 polycomb repressive complex 2 subunit | Czasami (5–29%) | W 2 chorobach |
| FANCAFA complementation group A | Czasami (5–29%) | W 2 chorobach |
| FANCBFA complementation group B | Czasami (5–29%) | W 2 chorobach |
| FANCCFA complementation group C | Czasami (5–29%) | W 2 chorobach |
| FANCD2FA complementation group D2 | Czasami (5–29%) | W 2 chorobach |
| FANCEFA complementation group E | Czasami (5–29%) | W 2 chorobach |
| FANCGFA complementation group G | Czasami (5–29%) | W 1 chorobie |
| FANCIFA complementation group I | Czasami (5–29%) | W 1 chorobie |
| FANCLFA complementation group L | Czasami (5–29%) | W 1 chorobie |
| FANCMFA complementation group M | Czasami (5–29%) | W 1 chorobie |
| FBN1fibrillin 1 | Czasami (5–29%) | W 1 chorobie |
| FBXL4F-box and leucine rich repeat protein 4 | Czasami (5–29%) | W 1 chorobie |
| FBXO11F-box protein 11 | Czasami (5–29%) | W 1 chorobie |
| FBXW7F-box and WD repeat domain containing 7 | Czasami (5–29%) | W 1 chorobie |
| FGFR3fibroblast growth factor receptor 3 | Czasami (5–29%) | W 2 chorobach |
| FIG4FIG4 phosphoinositide 5-phosphatase | Czasami (5–29%) | W 2 chorobach |
| FLGfilaggrin | Czasami (5–29%) | W 1 chorobie |
| FRAS1Fraser extracellular matrix complex subunit 1 | Czasami (5–29%) | W 2 chorobach |
| FREM2FRAS1 related extracellular matrix 2 | Czasami (5–29%) | W 1 chorobie |
| FUZfuzzy planar cell polarity protein | Czasami (5–29%) | W 1 chorobie |
| GABRDgamma-aminobutyric acid type A receptor subunit delta | Czasami (5–29%) | W 1 chorobie |
| GALTgalactose-1-phosphate uridylyltransferase | Czasami (5–29%) | W 1 chorobie |
| GFM2GTP dependent ribosome recycling factor mitochondrial 2 | Czasami (5–29%) | W 1 chorobie |
| GKglycerol kinase | Czasami (5–29%) | W 1 chorobie |
| GLI3GLI family zinc finger 3 | Czasami (5–29%) | W 5 chorobach |
| GMPPBGDP-mannose pyrophosphorylase B | Czasami (5–29%) | W 1 chorobie |
| GNB2G protein subunit beta 2 | Czasami (5–29%) | W 1 chorobie |
| GP1BBglycoprotein Ib platelet subunit beta | Czasami (5–29%) | W 1 chorobie |
| GPR161G protein-coupled receptor 161 | Czasami (5–29%) | W 1 chorobie |
| GRB10growth factor receptor bound protein 10 | Czasami (5–29%) | W 1 chorobie |
| GRIA2glutamate ionotropic receptor AMPA type subunit 2 | Czasami (5–29%) | W 1 chorobie |
| GRIA3glutamate ionotropic receptor AMPA type subunit 3 | Czasami (5–29%) | W 1 chorobie |
| GRIN2Bglutamate ionotropic receptor NMDA type subunit 2B | Czasami (5–29%) | W 1 chorobie |
| GRIP1glutamate receptor interacting protein 1 | Czasami (5–29%) | W 1 chorobie |
| GTF2E2general transcription factor IIE subunit 2 | Czasami (5–29%) | W 1 chorobie |
| GTF2H5general transcription factor IIH subunit 5 | Czasami (5–29%) | W 1 chorobie |
| GTF2Igeneral transcription factor IIi | Czasami (5–29%) | W 1 chorobie |
| GTF2IRD1GTF2I repeat domain containing 1 | Czasami (5–29%) | W 1 chorobie |
| GTF2IRD2GTF2I repeat domain containing 2 | Czasami (5–29%) | W 1 chorobie |
| H1-4H1.4 linker histone, cluster member | Czasami (5–29%) | W 1 chorobie |
| H19H19 imprinted maternally expressed transcript | Czasami (5–29%) | W 2 chorobach |
| HDAC4histone deacetylase 4 | Czasami (5–29%) | W 1 chorobie |
| HES7hes family bHLH transcription factor 7 | Czasami (5–29%) | W 1 chorobie |
| HIBCH3-hydroxyisobutyryl-CoA hydrolase | Czasami (5–29%) | W 1 chorobie |
| HIRAhistone cell cycle regulator | Czasami (5–29%) | W 1 chorobie |
| HMGA2high mobility group AT-hook 2 | Czasami (5–29%) | W 1 chorobie |
| HNF1BHNF1 homeobox B | Czasami (5–29%) | W 1 chorobie |
| HOXD13homeobox D13 | Czasami (5–29%) | W 1 chorobie |
| HYLS1HYLS1 centriolar and ciliogenesis associated | Czasami (5–29%) | W 1 chorobie |
| IER3IP1immediate early response 3 interacting protein 1 | Czasami (5–29%) | W 1 chorobie |
| IFT172intraflagellar transport 172 | Czasami (5–29%) | W 1 chorobie |
| IFT27intraflagellar transport 27 | Czasami (5–29%) | W 1 chorobie |
| IFT74intraflagellar transport 74 | Czasami (5–29%) | W 1 chorobie |
| IGF2insulin like growth factor 2 | Czasami (5–29%) | W 3 chorobach |
| JMJD1Cjumonji domain containing 1C | Czasami (5–29%) | W 1 chorobie |
| KAT6Alysine acetyltransferase 6A | Czasami (5–29%) | W 1 chorobie |
| KCNAB2potassium voltage-gated channel subfamily A regulatory beta subunit 2 | Czasami (5–29%) | W 1 chorobie |
| KCNQ1OT1KCNQ1 opposite strand/antisense transcript 1 | Czasami (5–29%) | W 2 chorobach |
| KDM3Blysine demethylase 3B | Czasami (5–29%) | W 1 chorobie |
| KIF7kinesin family member 7 | Czasami (5–29%) | W 3 chorobach |
| KMT2Alysine methyltransferase 2A | Czasami (5–29%) | W 1 chorobie |
| KMT5Blysine methyltransferase 5B | Czasami (5–29%) | W 1 chorobie |
| LFNGLFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase | Czasami (5–29%) | W 1 chorobie |
| LHX1LIM homeobox 1 | Czasami (5–29%) | W 1 chorobie |
| LHX4LIM homeobox 4 | Czasami (5–29%) | W 1 chorobie |
| LIMK1LIM domain kinase 1 | Czasami (5–29%) | W 1 chorobie |
| LMBR1limb development membrane protein 1 | Czasami (5–29%) | W 1 chorobie |
| LMOD1leiomodin 1 | Czasami (5–29%) | W 1 chorobie |
| LMX1BLIM homeobox transcription factor 1 beta | Czasami (5–29%) | W 1 chorobie |
| LUZP1leucine zipper protein 1 | Czasami (5–29%) | W 1 chorobie |
| LZTFL1leucine zipper transcription factor like 1 | Czasami (5–29%) | W 1 chorobie |
| MAD2L2mitotic arrest deficient 2 like 2 | Czasami (5–29%) | W 1 chorobie |
| MAP3K7mitogen-activated protein kinase kinase kinase 7 | Czasami (5–29%) | W 1 chorobie |
| MAPRE2microtubule associated protein RP/EB family member 2 | Czasami (5–29%) | W 2 chorobach |
| MBD5methyl-CpG binding domain protein 5 | Czasami (5–29%) | W 1 chorobie |
| MC2Rmelanocortin 2 receptor | Czasami (5–29%) | W 1 chorobie |
| MED13Lmediator complex subunit 13L | Czasami (5–29%) | W 2 chorobach |
| MEG3maternally expressed 3 | Czasami (5–29%) | W 2 chorobach |
| MESP2mesoderm posterior bHLH transcription factor 2 | Czasami (5–29%) | W 1 chorobie |
| METTL27methyltransferase like 27 | Czasami (5–29%) | W 1 chorobie |
| MID1midline 1 | Czasami (5–29%) | W 2 chorobach |
| MMP23Bmatrix metallopeptidase 23B | Czasami (5–29%) | W 1 chorobie |
| MPLKIPM-phase specific PLK1 interacting protein | Czasami (5–29%) | W 1 chorobie |
| MRAPmelanocortin 2 receptor accessory protein | Czasami (5–29%) | W 1 chorobie |
| MTMR14myotubularin related protein 14 | Czasami (5–29%) | W 1 chorobie |
| MTORmechanistic target of rapamycin kinase | Czasami (5–29%) | W 2 chorobach |
| MYF6myogenic factor 6 | Czasami (5–29%) | W 1 chorobie |
| MYH11myosin heavy chain 11 | Czasami (5–29%) | W 1 chorobie |
| MYLKmyosin light chain kinase | Czasami (5–29%) | W 1 chorobie |
| MYT1Lmyelin transcription factor 1 like | Czasami (5–29%) | W 1 chorobie |
| NCF1neutrophil cytosolic factor 1 | Czasami (5–29%) | W 1 chorobie |
| NDPnorrin cystine knot growth factor NDP | Czasami (5–29%) | W 1 chorobie |
| NNTnicotinamide nucleotide transhydrogenase | Czasami (5–29%) | W 2 chorobach |
| NPHP1nephrocystin 1 | Czasami (5–29%) | W 1 chorobie |
| OTUD5OTU deubiquitinase 5 | Czasami (5–29%) | W 1 chorobie |
| OTUD6BOTU deubiquitinase 6B | Czasami (5–29%) | W 2 chorobach |
| PALB2partner and localizer of BRCA2 | Czasami (5–29%) | W 1 chorobie |
| PAX2paired box 2 | Czasami (5–29%) | W 1 chorobie |
| PBX1PBX homeobox 1 | Czasami (5–29%) | W 2 chorobach |
| PDPNpodoplanin | Czasami (5–29%) | W 1 chorobie |
| PHIPPHIP subunit of CUL4-Ring ligase complex | Czasami (5–29%) | W 2 chorobach |
| PIEZO2piezo type mechanosensitive ion channel component 2 | Czasami (5–29%) | W 3 chorobach |
| PIGAphosphatidylinositol glycan anchor biosynthesis class A | Czasami (5–29%) | W 1 chorobie |
| PIGSphosphatidylinositol glycan anchor biosynthesis class S | Czasami (5–29%) | W 1 chorobie |
| PLAG1PLAG1 zinc finger | Czasami (5–29%) | W 1 chorobie |
| POLR1BRNA polymerase I subunit B | Czasami (5–29%) | W 1 chorobie |
| POLR1CRNA polymerase I and III subunit C | Czasami (5–29%) | W 1 chorobie |
| POLR1DRNA polymerase I and III subunit D | Czasami (5–29%) | W 1 chorobie |
| PORcytochrome p450 oxidoreductase | Czasami (5–29%) | W 2 chorobach |
| POU3F3POU class 3 homeobox 3 | Czasami (5–29%) | W 1 chorobie |
| POU6F2POU class 6 homeobox 2 | Czasami (5–29%) | W 1 chorobie |
| PPP1R15Bprotein phosphatase 1 regulatory subunit 15B | Czasami (5–29%) | W 1 chorobie |
| PRDM16PR/SET domain 16 | Czasami (5–29%) | W 1 chorobie |
| PRKCZprotein kinase C zeta | Czasami (5–29%) | W 1 chorobie |
| PTCH1patched 1 | Czasami (5–29%) | W 1 chorobie |
| PTCH2patched 2 | Czasami (5–29%) | W 1 chorobie |
| RAC1Rac family small GTPase 1 | Czasami (5–29%) | W 1 chorobie |
| RAC3Rac family small GTPase 3 | Czasami (5–29%) | W 1 chorobie |
| RAD51RAD51 recombinase | Czasami (5–29%) | W 1 chorobie |
| RARBretinoic acid receptor beta | Czasami (5–29%) | W 1 chorobie |
| RBM10RNA binding motif protein 10 | Czasami (5–29%) | W 1 chorobie |
| RBMY1A1RNA binding motif protein Y-linked family 1 member A1 | Czasami (5–29%) | W 1 chorobie |
| RECQL4RecQ like helicase 4 | Czasami (5–29%) | W 2 chorobach |
| REREarginine-glutamic acid dipeptide repeats | Czasami (5–29%) | W 3 chorobach |
| RESTRE1 silencing transcription factor | Czasami (5–29%) | W 1 chorobie |
| RFC2replication factor C subunit 2 | Czasami (5–29%) | W 1 chorobie |
| RFWD3ring finger and WD repeat domain 3 | Czasami (5–29%) | W 1 chorobie |
| RIPPLY2ripply transcriptional repressor 2 | Czasami (5–29%) | W 1 chorobie |
| RNF113Aring finger protein 113A | Czasami (5–29%) | W 1 chorobie |
| RNU2-2RNA, U2 small nuclear 2 | Czasami (5–29%) | W 1 chorobie |
| RNU5B-1RNA, U5B small nuclear 1 | Czasami (5–29%) | W 1 chorobie |
| RORARAR related orphan receptor A | Czasami (5–29%) | W 1 chorobie |
| RREB1ras responsive element binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| RTL1retrotransposon Gag like 1 | Czasami (5–29%) | W 2 chorobach |
| RTTNrotatin | Czasami (5–29%) | W 1 chorobie |
| SATB2SATB homeobox 2 | Czasami (5–29%) | W 1 chorobie |
| SCAPERS-phase cyclin A associated protein in the ER | Czasami (5–29%) | W 1 chorobie |
| SCLT1sodium channel and clathrin linker 1 | Czasami (5–29%) | W 1 chorobie |
| SDCCAG8SHH signaling and ciliogenesis regulator SDCCAG8 | Czasami (5–29%) | W 1 chorobie |
| SEC24CSEC24 homolog C, COPII component | Czasami (5–29%) | W 1 chorobie |
| SETBP1SET binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| SIN3ASIN3 transcription regulator family member A | Czasami (5–29%) | W 1 chorobie |
| SKISKI proto-oncogene | Czasami (5–29%) | W 3 chorobach |
| SLC16A2solute carrier family 16 member 2 | Czasami (5–29%) | W 1 chorobie |
| SLC19A2solute carrier family 19 member 2 | Czasami (5–29%) | W 1 chorobie |
| SLC26A2solute carrier family 26 member 2 | Czasami (5–29%) | W 1 chorobie |
| SLX4SLX4 structure-specific endonuclease subunit | Czasami (5–29%) | W 2 chorobach |
| SMOC1SPARC related modular calcium binding 1 | Czasami (5–29%) | W 1 chorobie |
| SMSspermine synthase | Czasami (5–29%) | W 2 chorobach |
| SPENspen family transcriptional repressor | Czasami (5–29%) | W 1 chorobie |
| SRCAPSnf2 related CREBBP activator protein | Czasami (5–29%) | W 3 chorobach |
| STARsteroidogenic acute regulatory protein | Czasami (5–29%) | W 1 chorobie |
| STRA6signaling receptor and transporter of retinol STRA6 | Czasami (5–29%) | W 2 chorobach |
| STSsteroid sulfatase | Czasami (5–29%) | W 3 chorobach |
| STX1Asyntaxin 1A | Czasami (5–29%) | W 1 chorobie |
| STXBP1syntaxin binding protein 1 | Czasami (5–29%) | W 1 chorobie |
| SUFUSUFU negative regulator of hedgehog signaling | Czasami (5–29%) | W 1 chorobie |
| TAF6TATA-box binding protein associated factor 6 | Czasami (5–29%) | W 1 chorobie |
| TARS1threonyl-tRNA synthetase 1 | Czasami (5–29%) | W 1 chorobie |
| TBCEtubulin folding cofactor E | Czasami (5–29%) | W 2 chorobach |
| TBL2transducin beta like 2 | Czasami (5–29%) | W 1 chorobie |
| TBX22T-box transcription factor 22 | Czasami (5–29%) | W 1 chorobie |
| TBX6T-box transcription factor 6 | Czasami (5–29%) | W 1 chorobie |
| TCF4transcription factor 4 | Czasami (5–29%) | W 2 chorobach |
| TCOF1treacle ribosome biogenesis factor 1 | Czasami (5–29%) | W 2 chorobach |
| THOC2THO complex subunit 2 | Czasami (5–29%) | W 1 chorobie |
| TMEM270transmembrane protein 270 | Czasami (5–29%) | W 1 chorobie |
| TMEM94transmembrane protein 94 | Czasami (5–29%) | W 1 chorobie |
| TNRC6Btrinucleotide repeat containing adaptor 6B | Czasami (5–29%) | W 1 chorobie |
| TOGARAM1TOG array regulator of axonemal microtubules 1 | Czasami (5–29%) | W 1 chorobie |
| TRIM28tripartite motif containing 28 | Czasami (5–29%) | W 1 chorobie |
| TRIM32tripartite motif containing 32 | Czasami (5–29%) | W 1 chorobie |
| TRIP13thyroid hormone receptor interactor 13 | Czasami (5–29%) | W 1 chorobie |
| TRIP4thyroid hormone receptor interactor 4 | Czasami (5–29%) | W 1 chorobie |
| TRPM3transient receptor potential cation channel subfamily M member 3 | Czasami (5–29%) | W 1 chorobie |
| TRRAPtransformation/transcription domain associated protein | Czasami (5–29%) | W 1 chorobie |
| TSPY1testis specific protein Y-linked 1 | Czasami (5–29%) | W 1 chorobie |
| TTC8tetratricopeptide repeat domain 8 | Czasami (5–29%) | W 1 chorobie |
| TUBBtubulin beta class I | Czasami (5–29%) | W 1 chorobie |
| TWIST1twist family bHLH transcription factor 1 | Czasami (5–29%) | W 1 chorobie |
| TXNRD2thioredoxin reductase 2 | Czasami (5–29%) | W 1 chorobie |
| UBA1ubiquitin like modifier activating enzyme 1 | Czasami (5–29%) | W 2 chorobach |
| UBE2Aubiquitin conjugating enzyme E2 A | Czasami (5–29%) | W 1 chorobie |
| UBE2Tubiquitin conjugating enzyme E2 T | Czasami (5–29%) | W 1 chorobie |
| UBE4Bubiquitination factor E4B | Czasami (5–29%) | W 1 chorobie |
| UFD1ubiquitin recognition factor in ER associated degradation 1 | Czasami (5–29%) | W 1 chorobie |
| USP9Yubiquitin specific peptidase 9 Y-linked | Czasami (5–29%) | W 1 chorobie |
| VAC14VAC14 component of PIKFYVE complex | Czasami (5–29%) | W 1 chorobie |
| VANGL1VANGL planar cell polarity protein 1 | Czasami (5–29%) | W 1 chorobie |
| VPS13Bvacuolar protein sorting 13 homolog B | Czasami (5–29%) | W 1 chorobie |
| VPS37DVPS37D subunit of ESCRT-I | Czasami (5–29%) | W 1 chorobie |
| WDR62WD repeat domain 62 | Czasami (5–29%) | W 1 chorobie |
| WDR83OSWD repeat domain 83 opposite strand | Czasami (5–29%) | W 1 chorobie |
| WNT7BWnt family member 7B | Czasami (5–29%) | W 1 chorobie |
| XRCC2X-ray repair cross complementing 2 | Czasami (5–29%) | W 1 chorobie |
| YY1YY1 transcription factor | Czasami (5–29%) | W 2 chorobach |
| ZMYM2zinc finger MYM-type containing 2 | Czasami (5–29%) | W 1 chorobie |
| ZNF462zinc finger protein 462 | Czasami (5–29%) | W 1 chorobie |
| ZNF699zinc finger protein 699 | Czasami (5–29%) | W 1 chorobie |
| ACBD6acyl-CoA binding domain containing 6 | Rzadko (1–4%) | W 1 chorobie |
| ALKALK receptor tyrosine kinase | Rzadko (1–4%) | W 1 chorobie |
| APC2APC regulator of Wnt signaling pathway 2 | Rzadko (1–4%) | W 1 chorobie |
| CLCN4Cl-/H+ antiporter 4 | Rzadko (1–4%) | W 1 chorobie |
| ERCC1ERCC excision repair 1, endonuclease non-catalytic subunit | Rzadko (1–4%) | W 1 chorobie |
| FGF10fibroblast growth factor 10 | Rzadko (1–4%) | W 1 chorobie |
| SOX5SRY-box transcription factor 5 | Rzadko (1–4%) | W 1 chorobie |
| ACTBactin beta | Nie odnotowano | W 1 chorobie |
| AKR1C2aldo-keto reductase family 1 member C2 | Nie odnotowano | W 1 chorobie |
| AKR1C4aldo-keto reductase family 1 member C4 | Nie odnotowano | W 1 chorobie |
| ATRATR checkpoint kinase | Nie odnotowano | W 1 chorobie |
| AXLAXL receptor tyrosine kinase | Nie odnotowano | W 1 chorobie |
| BLMBLM RecQ like helicase | Nie odnotowano | W 1 chorobie |
| BUB1BBUB1 mitotic checkpoint serine/threonine kinase B | Nie odnotowano | W 1 chorobie |
| C2CD3C2 domain containing 3 centriole elongation regulator | Nie odnotowano | W 1 chorobie |
| CCBE1collagen and calcium binding EGF domains 1 | Nie odnotowano | W 1 chorobie |
| CCDC174coiled-coil domain containing 174 | Nie odnotowano | W 1 chorobie |
| CDC42cell division cycle 42 | Nie odnotowano | W 1 chorobie |
| CDCA7cell division cycle associated 7 | Nie odnotowano | W 1 chorobie |
| CEP120centrosomal protein 120 | Nie odnotowano | W 1 chorobie |
| CLP1cleavage factor polyribonucleotide kinase subunit 1 | Nie odnotowano | W 1 chorobie |
| COLEC11collectin subfamily member 11 | Nie odnotowano | W 1 chorobie |
| CUL4Bcullin 4B | Nie odnotowano | W 1 chorobie |
| DHODHdihydroorotate dehydrogenase (quinone) | Nie odnotowano | W 1 chorobie |
| DKC1dyskerin pseudouridine synthase 1 | Nie odnotowano | W 1 chorobie |
| DNAJC21DnaJ heat shock protein family (Hsp40) member C21 | Nie odnotowano | W 1 chorobie |
| EFNB1ephrin B1 | Nie odnotowano | W 1 chorobie |
| FLNAfilamin A | Nie odnotowano | W 1 chorobie |
| FTOFTO alpha-ketoglutarate dependent dioxygenase | Nie odnotowano | W 1 chorobie |
| GLE1GLE1 RNA export mediator | Nie odnotowano | W 1 chorobie |
| GLI2GLI family zinc finger 2 | Nie odnotowano | W 2 chorobach |
| INSL3insulin like 3 | Nie odnotowano | W 1 chorobie |
| KCNQ1potassium voltage-gated channel subfamily Q member 1 | Nie odnotowano | W 1 chorobie |
| KMT2Elysine methyltransferase 2E (inactive) | Nie odnotowano | W 1 chorobie |
| NOTCH2notch receptor 2 | Nie odnotowano | W 1 chorobie |
| OGTO-linked N-acetylglucosamine (GlcNAc) transferase | Nie odnotowano | W 1 chorobie |
| OPHN1oligophrenin 1 | Nie odnotowano | W 1 chorobie |
| PHGDHphosphoglycerate dehydrogenase | Nie odnotowano | W 1 chorobie |
| PORCNporcupine O-acyltransferase | Nie odnotowano | W 1 chorobie |
| RLIMring finger protein, LIM domain interacting | Nie odnotowano | W 1 chorobie |
| SGPL1sphingosine-1-phosphate lyase 1 | Nie odnotowano | W 1 chorobie |
| SIX6SIX homeobox 6 | Nie odnotowano | W 1 chorobie |
| SRA1steroid receptor RNA activator 1 | Nie odnotowano | W 1 chorobie |
| TFAP2Atranscription factor AP-2 alpha | Nie odnotowano | W 1 chorobie |
| TGDSTDP-glucose 4,6-dehydratase | Nie odnotowano | W 1 chorobie |
| TINF2TERF1 interacting nuclear factor 2 | Nie odnotowano | W 1 chorobie |
| TP63tumor protein p63 | Nie odnotowano | W 1 chorobie |
| TPM2tropomyosin 2 | Nie odnotowano | W 1 chorobie |
| UBR1ubiquitin protein ligase E3 component n-recognin 1 | Nie odnotowano | W 1 chorobie |
| WNK3WNK lysine deficient protein kinase 3 | Nie odnotowano | W 1 chorobie |
| ZMIZ1zinc finger MIZ-type containing 1 | Nie odnotowano | W 1 chorobie |
Jak często występuje wśród osób z jedną z chorób związanych z tym genem, najczęściej spośród wszystkich, według danych Human Phenotype Ontology. Te strony opisują cechy i badania, na których się opierają; nie są diagnozą, a w sprawie objawów należy zwrócić się do lekarza lub doradcy genetycznego.
Cechy podrzędne
Cechy nadrzędne
Skąd pochodzą te dane
- Human Phenotype Ontology, wydanie 2026-09-01: cecha, jej nazwy, definicja oraz geny z nią powiązane. Więcej informacji znajdą Państwo na stronie hpo.jax.org.
- Wydanie danych 2026.10.16-c6eea6bf.
Komu pomagamyNasza naukaProduktyWyniki
Zaloguj sięZapytajZamówod 449 $
Jeden test. Odpowiedzi na całe życie.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni